Bnp Paribas Financial Markets / LLY
Bnp Paribas Financial Markets’s Eli Lilly & Co Position
Does Bnp Paribas Financial Markets own Eli Lilly & Co (LLY)? Yes — 825.9K shares worth $760M (+0.37% of its 13F portfolio) as of Q1 2026, up from 709.2K shares the prior filed quarter.
Position Value
$760M
Q1 2026
Shares
825.9K
% of Portfolio
+0.37%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 825.9K | $760M | +0.37% |
| Q4 2025 | 709.2K | $762M | +0.35% |
| Q3 2025 | 475.9K | $363M | +0.19% |
| Q2 2025 | 834.4K | $650M | +0.37% |
| Q1 2025 | 854.4K | $706M | +0.42% |
| Q4 2024 | 687.6K | $531M | +0.30% |
| Q3 2024 | 710.0K | $629M | +0.42% |
| Q2 2024 | 710.3K | $643M | +0.52% |
| Q1 2024 | 757.5K | $589M | +0.52% |
| Q4 2023 | 258.0K | $150M | +0.17% |
| Q3 2023 | 466.0K | $250M | +0.32% |
| Q2 2023 | 317.9K | $149M | +0.19% |
| Q1 2023 | 529.9K | $182M | +0.25% |
| Q4 2022 | 466.4K | $171M | +0.26% |
| Q3 2022 | 260.4K | $84.2B | +0.13% |
| Q2 2022 | 464.4K | $150.6B | +0.24% |
| Q1 2022 | 428.7K | $122.8B | +0.17% |
| Q4 2021 | 297.8K | $82.2B | +0.12% |
| Q3 2021 | 273.4K | $63.2B | +0.09% |
| Q2 2021 | 163.2K | $37.5B | +0.05% |
| Q1 2021 | 140.0K | $26.2B | +0.04% |
| Q4 2020 | 138.3K | $23.3B | +0.04% |
| Q3 2020 | 629.2K | $93.1B | +0.13% |
| Q2 2020 | 337.7K | $55.4B | +0.10% |
| Q1 2020 | 1.89M | $262.7B | +0.54% |
| Q4 2019 | 1.97M | $258.7B | +0.47% |
| Q3 2019 | 1.99M | $222.8B | +0.40% |
| Q2 2019 | 2.44M | $270.2B | +0.54% |
| Q1 2019 | 1.88M | $244.3B | +0.53% |
| Q4 2018 | 2.02M | $233.6B | +0.55% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bnp Paribas Financial Markets’s full portfolio or all institutional holders of LLY.